Cargando…

Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases

SCA1, SCA2, and SCA3 are the most common forms of SCAs among the polyglutamine disorders, which include Huntington’s Disease (HD). We investigated the relationship between leukocyte telomere length (LTL) and the phenotype of SCA1, SCA2, and SCA3, comparing them with HD. The results showed that LTL w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scarabino, Daniela, Veneziano, Liana, Fiore, Alessia, Nethisinghe, Suran, Mantuano, Elide, Garcia-Moreno, Hector, Bellucci, Gianmarco, Solanky, Nita, Morello, Maria, Zanni, Ginevra, Corbo, Rosa Maria, Giunti, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332235/ https://www.ncbi.nlm.nih.gov/pubmed/35892638 http://dx.doi.org/10.3390/antiox11081436

Ejemplares similares

Leukocyte Telomere Length as Potential Biomarker of HD Progression: A Follow-Up Study
por: Scarabino, Daniela, et al.
Publicado: (2022)

Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?
por: Mantuano, Elide, et al.
Publicado: (2019)

The Role of Interruptions in polyQ in the Pathology of SCA1
por: Menon, Rajesh P., et al.
Publicado: (2013)

PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption
por: Nethisinghe, Suran, et al.
Publicado: (2018)

Molecular mechanism of Spinocerebellar Ataxia type 6: glutamine repeat disorder, channelopathy and transcriptional dysregulation. The multifaceted aspects of a single mutation
por: Giunti, Paola, et al.
Publicado: (2015)

Analysis of the Association Between TERC and TERT Genetic Variation and Leukocyte Telomere Length and Human Lifespan—A Follow-Up Study
por: Scarabino, Daniela, et al.
Publicado: (2019)

Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression?
por: Corbo, Rosa Maria, et al.
Publicado: (2020)

Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study
por: Romano, Silvia, et al.
Publicado: (2022)

A Novel De Novo Mutation of the TITF1/NKX2-1 Gene Causing Ataxia, Benign Hereditary Chorea, Hypothyroidism and a Pituitary Mass in a UK Family and Review of the Literature
por: Veneziano, Liana, et al.
Publicado: (2014)

Episodic Ataxias: Faux or Real?
por: Giunti, Paola, et al.
Publicado: (2020)

Altered pituitary morphology as a sign of benign hereditary chorea caused by TITF1/NKX2.1 mutations
por: Thust, Steffi, et al.
Publicado: (2022)

Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACS
por: Nethisinghe, Suran, et al.
Publicado: (2021)

Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis: Coaggregation of polyQ proteins
por: Hong, Jun-Ye, et al.
Publicado: (2023)

Sequencing analysis of the SCA6 CAG expansion excludes an influence of repeat interruptions on disease onset
por: Wiethoff, Sarah, et al.
Publicado: (2018)

PolyQ 2.0: an improved version of PolyQ, a database of human polyglutamine proteins
por: Li, Chen, et al.
Publicado: (2016)

PolyQ 2.0: an improved version of PolyQ, a database of human polyglutamine proteins
por: Li, Chen, et al.
Publicado: (2016)

Small-molecule modulators of TRMT2A decrease PolyQ aggregation and PolyQ-induced cell death
por: Margreiter, Michael A, et al.
Publicado: (2021)

Interruptions of the FXN GAA Repeat Tract Delay the Age at Onset of Friedreich’s Ataxia in a Location Dependent Manner
por: Nethisinghe, Suran, et al.
Publicado: (2021)

Undoing SUMO aids polyQ AR
por: Lieberman, Andrew P., et al.
Publicado: (2015)

The Protein Structure Context of PolyQ Regions
por: Totzeck, Franziska, et al.
Publicado: (2017)

Between Interactions and Aggregates: The PolyQ Balance
por: Mier, Pablo, et al.
Publicado: (2021)

Leukocyte telomere dynamics in the elderly
por: Steenstrup, Troels, et al.
Publicado: (2013)

A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia
por: Hasan, Sonia, et al.
Publicado: (2017)

Sequencing analysis of the spinal bulbar muscular atrophy CAG expansion reveals absence of repeat interruptions()
por: Fratta, Pietro, et al.
Publicado: (2014)

Alleviating neurodegeneration in Drosophila models of PolyQ diseases
por: Long, Zhe, et al.
Publicado: (2014)

PolyQ length co-evolution in neural proteins
por: Vaglietti, Serena, et al.
Publicado: (2021)

PolyQ Database—an integrated database on polyglutamine diseases
por: Estevam, Bernardo, et al.
Publicado: (2023)

Leukocyte telomere length and mortality risk in patients with type 2 diabetes
por: Bonfigli, Anna Rita, et al.
Publicado: (2016)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Amyloid-Like Fibril Formation by PolyQ Proteins: A Critical Balance between the PolyQ Length and the Constraints Imposed by the Host Protein
por: Scarafone, Natacha, et al.
Publicado: (2012)

TERC Variants Associated with Short Leukocyte Telomeres: Implication of Higher Early Life Leukocyte Telomere Attrition as Assessed by the Blood-and-Muscle Model
por: Toupance, Simon, et al.
Publicado: (2020)

Telomere shortening in leukocyte subpopulations in depression
por: Karabatsiakis, Alexander, et al.
Publicado: (2014)

Alcohol consumption and leukocyte telomere length
por: Dixit, Shalini, et al.
Publicado: (2019)

A reduction in Drp1-mediated fission compromises mitochondrial health in autosomal recessive spastic ataxia of Charlevoix Saguenay
por: Bradshaw, Teisha Y., et al.
Publicado: (2016)

Offspring's Leukocyte Telomere Length, Paternal Age, and Telomere Elongation in Sperm
por: Kimura, Masayuki, et al.
Publicado: (2008)

A wearable motion capture suit and machine learning predict disease progression in Friedreich’s ataxia
por: Kadirvelu, Balasundaram, et al.
Publicado: (2023)

An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases
por: Fiszer, Agnieszka, et al.
Publicado: (2012)

Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases
por: Gkekas, Ioannis, et al.
Publicado: (2021)

Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity
por: Tsai, Tien-Ying, et al.
Publicado: (2023)

Lower urinary tract and bowel dysfunction in spinocerebellar ataxias
por: Afonso Ribeiro, Joana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nejmk78a61k8hqgdtt7q1hb0ur